10
Participants
Start Date
November 13, 2019
Primary Completion Date
July 11, 2020
Study Completion Date
July 11, 2020
Radiesse (calcium hydroxylpatite)
"RADIESSE® injectable implant is a sterile, non-pyrogenic, semi-solid, cohesive implant, whose principle component is synthetic calcium hydroxylapatite (CaHA) suspended in a gel carrier of sterile water for injection, glycerin and sodium carboxymethylcellulose. RADIESSE injectable implant has a CaHA particle size range of 25-45 microns. RADIESSE is available in 1.5cc and 0.8cc pre-filled syringes.~RADIESSE injectable implant is indicated for subdermal implantation for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds and it is also intended for restoration and/or correction of the signs of facial fat loss (lipoatrophy)."
Erevna Innovations Inc, Montreal
Lead Sponsor
Erevna Innovations Inc.
OTHER